Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE Featured Partner For years, Ozempic has ...

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...

If you're considering weight loss medications like the popular GLP-1 agonists — like semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) — you're probably wondering whether your ...

The medication is indicated as an adjunct to a reduced–calorie diet and increased physical activity for chronic weight management.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. For the first time, a generic GLP-1 has been approved by ...

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...

INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival ...